Expression levels of CCR6 in prostate cancer are associated with clinical and pathologic features of more advanced and aggressive prostate cancer status, such as local tumor volume, Gleason score, and lymph node metastasis [46]. This evidence concerns the gene CCR6 and Familial prostate cancer.